Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma

被引：45
作者：
Leppaenen, Joni [1 ,2 ]
Lindholm, Ville [1 ,2 ]
Isohookana, Joel [1 ,2 ]
Haapasaari, Kirsi-Maria [1 ,2 ]
Karihtala, Peeter [1 ,2 ]
Lehenkari, Petri P. [1 ,2 ]
Saarnio, Juha [1 ,2 ]
Kauppila, Joonas H. [1 ,2 ,3 ,4 ]
Karttunen, Tuomo J. [1 ,2 ]
Helminen, Olli [1 ,2 ]
Huhta, Heikki [1 ,2 ]
机构：
[1] Univ Oulu, Med Res Ctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland
[2] Oulu Univ Hosp, Oulu, Finland
[3] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
来源：
PANCREAS | 2019年 / 48卷 / 01期
关键词：
extracellular matrix; fibronectin; pancreatic cancer; tenascin C; tumor-stroma ratio; INDEPENDENT PREDICTOR; PROGNOSTIC-FACTOR; BREAST-CANCER; SURVIVAL; MICROENVIRONMENT; EXPRESSION; PROGRESSION; CARCINOMA; ESOPHAGUS;
D O I：
10.1097/MPA.0000000000001195
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Objectives: Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma with increased expression of tenascin C and fibronectin. Their role and tumor-stroma ratio in PDAC are not well known. The aim of this study was to evaluate tenascin C and fibronectin expression and tumor-stroma ratio and their prognostic relevance in PDAC. Methods: Ninety-five resected PDACs were immunohistochemically stained for tenascin C and fibronectin, and the expression was separately assessed in tumor bulk and front. Tumor-stroma ratio was determined with sections stained with hematoxylin-eosin. Results: Tenascin C and fibronectin were abundantly expressed in the stroma of PDAC, but absent in adjacent normal pancreatic tissue. Fibronectin expression of the bulk was associated with high T class (P = 0.045). In the main analysis, tenascin C and fibronectin expression and tumor-stroma ratio were not associated with patient survival. In a subgroup analysis of early-stage PDAC (T1-T2 tumors), high tenascin C expression in the tumor bulk was associated with poor prognosis (hazard ratio, 8.23; 95% confidence interval, 2.71-24.96). Conclusions: Tenascin C and fibronectin are abundantly expressed in PDAC, but they seem to have no major association with patient survival. However, in early-stage PDAC, tenascin C expression of the tumor bulk may have prognostic impact. Tumor-stroma ratio has no prognostic value in PDAC.
引用
收藏
页码：43 / 48
页数：6
相关论文
共 50 条
[21]   Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study [J].
Scheer, Rene ;
Baidoshvili, Alexi ;
Zoidze, Shorena ;
Elferink, Marloes A. G. ;
Berkel, Annefleur E. M. ;
Klaase, Joost M. ;
van Diest, Paul J. .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (12) :466-474
[22]   Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer [J].
Chen, Ying ;
Zhang, Lei ;
Liu, Wenxin ;
Liu, Xiangyu .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[23]   Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor [J].
Souza da Silva, Ricella M. ;
Queiroga, Eduardo M. ;
Paz, Alexandre R. ;
Neves, Fabiana F. P. ;
Cunha, Karin S. ;
Dias, Eliane P. .
CLINICAL PATHOLOGY, 2021, 14
[24]   Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer [J].
Vendittelli, Pierpaolo ;
Bokhorst, John-Melle ;
Smeets, Esther M. M. ;
Kryklyva, Valentyna ;
Brosens, Lodewijk A. A. ;
Verbeke, Caroline ;
Litjens, Geert .
PLOS ONE, 2024, 19 (05)
[25]   Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma [J].
Daunke, Tina ;
Beckinger, Silje ;
Rahn, Sascha ;
Krueger, Sandra ;
Heckl, Steffen ;
Schaefer, Heiner ;
Wesch, Daniela ;
Pilarsky, Christian ;
Eckstein, Markus ;
Hartmann, Arndt ;
Roecken, Christoph ;
Wandmacher, Anna Maxi ;
Sebens, Susanne .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[26]   Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review [J].
Gao, Jinlai ;
Shen, Zhangguo ;
Deng, Zaixing ;
Mei, Lina .
FRONTIERS IN ONCOLOGY, 2021, 11
[27]   Tumor-stroma ratio is an independent predictor for survival in NSCLC [J].
Zhang, Tiehong ;
Xu, Jun ;
Shen, Hongchang ;
Dong, Wei ;
Ni, Yang ;
Du, Jiajun .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09) :11348-11355
[28]   One novel transfer learning-based CLIP model combined with self-attention mechanism for differentiating the tumor-stroma ratio in pancreatic ductal adenocarcinoma [J].
Liao, Hongfan ;
Yuan, Jiang ;
Liu, Chunhua ;
Zhang, Jiao ;
Yang, Yaying ;
Liang, Hongwei ;
Liu, Haotian ;
Chen, Shanxiong ;
Li, Yongmei .
RADIOLOGIA MEDICA, 2024, 129 (11) :1559-1574
[29]   Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels [J].
V. Monteiro, Maria ;
Ferreira, Luis P. ;
Rocha, Marta ;
Gaspar, Vitor M. ;
Mano, Joao F. .
BIOMATERIALS, 2022, 287
[30]   The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma [J].
Karjula, Topias ;
Kemi, Niko ;
Niskakangas, Anne ;
Mustonen, Olli ;
Puro, Iiris ;
Pohjanen, Vesa-Matti ;
Kuopio, Teijo ;
Elomaa, Hanna ;
Ahtiainen, Maarit ;
Mecklin, Jukka-Pekka ;
Seppala, Toni T. ;
Wirta, Erkki-Ville ;
Sihvo, Eero ;
Vayrynen, Juha P. ;
Yannopoulos, Fredrik ;
Helminen, Olli .
EJSO, 2023, 49 (07) :1298-1306
12345